Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Yasser Elborai"'
Autor:
GHALEB ELYAMANY, Nawaf ALKHAYAT, Omar AL SHARIF, Yasser ELBORAI, Mohammad AL SHAHRANI, Omar ALSUHAIBANI
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S15-S16 (2022)
Objective: NOTCH1 is now established to play a key role in the prognosis of several hematological malignancies. Notch proteins are multifaceted and involved in several key cellular functions with extensive crosstalk with other critical pathways; ther
Externí odkaz:
https://doaj.org/article/695929ea8a774e3b938e9fa9efc6256d
Autor:
Nawaf Alkhayat, Mohammad Alshahrani, Ghaleb Elyamany, Qanita Sedick, Walid Ibrahim, Hasna Hamzi, Amal Binhassan, Mohamed Othman, Saeed Alshieban, Mansour S. Aljabry, Shuaa Asiri, Muneerah Alzouman, Omar Alsuhaibani, Fahad Alabbas, Omar Alsharif, Yasser Elborai
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 33, Iss 1, Pp 1-9 (2021)
Abstract Background Hodgkin lymphoma (HL) is lymphoid neoplasm usually affecting lymphatic system; it accounts 3.6% of cancers in Saudi Arabia. Modern treatment protocols had shown particular success rates in overall-survival (OS) and event-free-surv
Externí odkaz:
https://doaj.org/article/4be7a1fa2d86480c9736eca49e7c675a
Autor:
Yasser Elborai, Mohammad Almutereen, Ossama M. Maher, Hanafy Hafez, Michelle A. Lee, Leslie Lehmann
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 32, Iss 1, Pp 1-7 (2020)
Abstract Background Treatment for malignant embryonal brain tumors in young children usually employs cycles of standardly dosed cisplatinum followed by high-dose carboplatinum-containing conditioning with single or tandem autologous stem cell rescue
Externí odkaz:
https://doaj.org/article/891fbaa6dc2c4bab9d1c14d8383ddd1f
Autor:
Fahad Alabbas, Ghaleb Elyamany, Nawaf Alkhayat, Mohammad AlShahrani, Walid Ibrahim, Yasser Elborai, Amal Binhassan, Hasna Hamzi, Nour Al Thibani, Sami Alakel, Faisal Alsharif, Omar Alsuhaibani, Omar Alsharif
Publikováno v:
Health Services Insights, Vol 14 (2021)
Advances in pediatric cancer treatment and dramatic improvement in long-term survival have made health-related quality of life (HRQOL) a priority. This study describes the HRQOL of Saudi children on cancer treatment, given the paucity of data on the
Externí odkaz:
https://doaj.org/article/ef75ff00faa34116b62c14c0dd65c168
Autor:
Nawaf Alkhayat, Ghaleb Elyamany, Yasser Elborai, Qanita Sedick, Mohammad Alshahrani, Omar Al Sharif, Abdulmalik Alenezy, Amjad Hammdan, Hatem Elghezal, Omar Alsuhaibani, Mansour S. Aljabry, May AlMoshary, Eman Al Mussaed
Publikováno v:
Molecular Cytogenetics, Vol 12, Iss 1, Pp 1-11 (2019)
Abstract Background Childhood Acute Leukemia (AL) is characterized by recurrent genetic aberrations in 60% of AML cases and 90% of ALL cases. Insufficient data exists of rare cytogenetic abnormalities in AL. Therefore, we tested rare cytogenetic abno
Externí odkaz:
https://doaj.org/article/b55d7fca52f44ddebb9ef81726568a3e
Autor:
Yasser Elborai, Nawaf Alkhayat, Ghaleb Elyamany, Mohammad Alshahrani, Walid Ibrahim, Mohamed Othman, Hasna Hamzi, Amal Binhassan, Mansour S Aljabry, Raniah Alqawahmed, Yasir alrusayni, Khadijah Abdulhaleem, Omar Alsuhaibani, Omar Alsharif
Publikováno v:
Rare Tumors, Vol 13 (2021)
Rare pediatric tumors are heterogeneous group containing a variety of histopathological diseases, they represent approximately 10% of all childhood cancers. These rare tumors had a diversity of histology and clinical behaviors that pose different cha
Externí odkaz:
https://doaj.org/article/f7c89fbd6f4546f8807de2a05bbc8364
Autor:
Mohammad Alshahrani, Ghaleb Elyamany, Qanita Sedick, Walid Ibrahim, Amal Mohamed, Mohamed Othman, Nour Al Thibani, Omar Alsuhaibani, Mohamed Al Amro, Ali Gharawi, Omar Al Sharif, Yasser Elborai, Fahad Alabbas, Amal Binhassan, May AlMoshary, Eman Al Mussaed, Nawaf Alkhayat
Publikováno v:
Health Services Insights, Vol 13 (2020)
In January 2020, the WHO declared the novel coronavirus (2019-nCoV) outbreak as a public health emergency of international concern. Due to the rapid spread of 2019-nCoV, all countries started preventive and precautionary measures to prevent COVID-19
Externí odkaz:
https://doaj.org/article/21504a6765404c68806001cfd9b306db
Autor:
Nawaf Alkhayat, Yasser Elborai, Omer Al Sharif, Mohammad Al Shahrani, Omar Alsuhaibani, Mohammed Awad, Hatem Elghezal, Inesse ben-abdallah Bouhajar, Mona Alfaraj, Eman Al Mussaed, Fahad Alabbas, Ghaleb Elyamany
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 11 (2017)
Background: Childhood acute lymphoblastic leukemia (ALL) is characterized by recurrent genetic aberrations. The identification of those abnormalities is clinically important because they are considered significant risk-stratifying markers. Aims: Ther
Externí odkaz:
https://doaj.org/article/211e9ee9ac7e4d9b9d263231b26114c2
Publikováno v:
Iranian Journal of Pharmaceutical Research : IJPR
This study was designed to evaluate the effect of Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms on MTX toxicity in pediatric Egyptian ALL patients. Ninety-Four of Pediatric ALL patients aged 3–13 years (7.6 ± 3.6) on oral maintena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1d2b276daf51ab4c272a98f42a4c7dd6
http://europepmc.org/articles/PMC8019867
http://europepmc.org/articles/PMC8019867
Autor:
YunZu Michele Wang, Ashley Teusink-Cross, Pooja Khandelwal, Parinda A. Mehta, M. Christa Krupski, Kasiani C. Myers, Adam S. Nelson, Ashish R Kumar, Amanda Flannery, Stella M. Davies, Sharat Chandra, J.J. Bleesing, Yasser Elborai, Michael Grimley
Publikováno v:
Transplantation. 106(2)
BACKGROUND Ruxolitinib, a JAK1/2 inhibitor, is used to treat chronic graft-versus-host-disease (cGVHD) in adult allogeneic hematopoietic stem cell transplant patients, but experience in children is limited, perhaps due to lack of pediatric dosing inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7bd8664ffdf3e2f4f9516cffc4d2d3d
https://pubmed.ncbi.nlm.nih.gov/33795598
https://pubmed.ncbi.nlm.nih.gov/33795598